Literature DB >> 11991728

Role of oxidative stress in myocardial hypertrophy and failure.

Douglas B Sawyer1, Deborah A Siwik, Lei Xiao, David R Pimentel, Krishna Singh, Wilson S Colucci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11991728     DOI： 10.1006/jmcc.2002.1526

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN： 0022-2828            Impact factor:   5.000


× No keyword cloud information.
  146 in total

Review 1.  Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury.

Authors:  Nina Kaludercic; Andrea Carpi; Roberta Menabò; Fabio Di Lisa; Nazareno Paolocci
Journal:  Biochim Biophys Acta       Date:  2010-09-24

2.  Oxidative posttranslational modifications mediate decreased SERCA activity and myocyte dysfunction in Galphaq-overexpressing mice.

Authors:  Steve Lancel; Fuzhong Qin; Shannon L Lennon; Jingmei Zhang; Xiaoyong Tong; Michael J Mazzini; Y James Kang; Deborah A Siwik; Richard A Cohen; Wilson S Colucci
Journal:  Circ Res       Date:  2010-05-27       Impact factor: 17.367

3.  Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Zucker obese rat.

Authors:  Xinli Zhou; Lixin Ma; Javad Habibi; Adam Whaley-Connell; Melvin R Hayden; Roger D Tilmon; Ashley N Brown; Jeong-A Kim; Vincent G Demarco; James R Sowers
Journal:  Hypertension       Date:  2010-02-22       Impact factor: 10.190

4.  Reversal of cardiac dysfunction by selective ET-A receptor antagonism.

Authors:  Anthony Allan; Andrew Fenning; Scott Levick; Andrew Hoey; Lindsay Brown
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

Review 5.  The role of reactive oxygen species in myocardial redox signaling and regulation.

Authors:  Demetrios Moris; Michael Spartalis; Eleni Tzatzaki; Eleftherios Spartalis; Georgia-Sofia Karachaliou; Andreas S Triantafyllis; Georgios I Karaolanis; Diamantis I Tsilimigras; Stamatios Theocharis
Journal:  Ann Transl Med       Date:  2017-08

6.  Requirement of Rac1 in the development of cardiac hypertrophy.

Authors:  Minoru Satoh; Hisakazu Ogita; Kyosuke Takeshita; Yasushi Mukai; David J Kwiatkowski; James K Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

7.  Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy.

Authors:  Mitsutaka Yamamoto; Guiping Yang; Chull Hong; Jing Liu; Eric Holle; Xianzhong Yu; Thomas Wagner; Stephen F Vatner; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

8.  Biochemical and mechanical dysfunction in a mouse model of desmin-related myopathy.

Authors:  Alina Maloyan; Hanna Osinska; Jan Lammerding; Richard T Lee; Oscar H Cingolani; David A Kass; John N Lorenz; Jeffrey Robbins
Journal:  Circ Res       Date:  2009-03-19       Impact factor: 17.367

9.  Cardiac-specific overexpression of catalase identifies hydrogen peroxide-dependent and -independent phases of myocardial remodeling and prevents the progression to overt heart failure in G(alpha)q-overexpressing transgenic mice.

Authors:  Fuzhong Qin; Shannon Lennon-Edwards; Steve Lancel; Andreia Biolo; Deborah A Siwik; David R Pimentel; Gerald W Dorn; Y James Kang; Wilson S Colucci
Journal:  Circ Heart Fail       Date:  2009-12-16       Impact factor: 8.790

10.  Inhibition of MAPK signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through reduction of inflammation.

Authors:  Lei-Lei Chen; Tie Bin Zhu; Hang Yin; Jun Huang; Lian Sheng Wang; Ke Jiang Cao; Zhi Jian Yang
Journal:  Mol Biol Rep       Date:  2009-11-12       Impact factor: 2.316
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.